6 recruiting, 5 active not recruiting, 1 not yet recruiting, 1 suspended. 14 Phase 3, 6 Phase 2.
Follow Biopsy Procedure: new trials by email Literature Review of Biopsy Procedure trials Research Report on Biopsy Procedure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis Biopsy Procedure, Biospecimen Collection, Breast Conservation Treatment - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma | Phase 3 | Recruiting | SWOG Cancer Research Network | 562 | 2027-03-09 | 2026-10-13 |
| Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial Bevacizumab, Biopsy Procedure, Biospecimen Collection - Metastatic Appendix Carcinoma, Metastatic Colorectal Carcinoma | Phase 3 | Recruiting | City of Hope Medical Center | 129 | 2027-01-04 | 2026-11-05 |
| Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - Stage II T Lymphoblastic Leukemia/Lymphoma, Stage III T Lymphoblastic Leukemia/Lymphoma | Phase 2 / Phase 3 | Not yet recruiting | Children's Oncology Group | 1708 | 2026-08-28 | 2026-07-30 |
| Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - CIC-Rearranged Sarcoma, Metastatic Ewing Sarcoma | Phase 2 / Phase 3 | Terminated | Children's Oncology Group | 2 | 2025-11-10 | 2026-10-05 |
| Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer Biopsy Procedure, Biospecimen Collection, Capecitabine - Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 | Phase 3 | Recruiting | NRG Oncology | 356 | 2025-08-21 | 2026-08-25 |
| Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative Biopsy Procedure, Biospecimen Collection, Computed Tomography - Lung Adenocarcinoma, Lung Adenosquamous Carcinoma | Phase 2 / Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 427 | 2022-10-07 | 2026-10-01 |
| Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma Biopsy Procedure, Bone Scan, Computed Tomography - Embryonal Rhabdomyosarcoma, Fusion-Negative Alveolar Rhabdomyosarcoma | Phase 3 | Recruiting | Children's Oncology Group | 205 | 2022-08-04 | 2026-08-25 |
| Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer Biopsy Procedure, Biospecimen Collection, Cisplatin - Renal Pelvis and Ureter Urothelial Carcinoma | Phase 2 / Phase 3 | Recruiting | National Cancer Institute (NCI) | 131 | 2021-11-12 | 2026-11-05 |
| De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer Biopsy Procedure, Biospecimen Collection, Cisplatin - Basaloid Squamous Cell Carcinoma, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Phase 2 / Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 384 | 2019-10-09 | 2026-07-02 |
| Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Biopsy Procedure, Biospecimen Collection, Carboplatin - Low Grade Fallopian Tube Serous Adenocarcinoma, Ovarian Low Grade Serous Adenocarcinoma | Phase 3 | Active not recruiting | NRG Oncology | 450 | 2019-09-20 | 2026-03-24 |
| Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer Biopsy Procedure, Biospecimen Collection, Colonoscopy - Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 344 | 2018-07-05 | 2026-11-02 |
| Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Best Practice, Biopsy Procedure, Biospecimen Collection - Childhood Extracranial Germ Cell Tumor, Extragonadal Embryonal Carcinoma | Phase 3 | Recruiting | Children's Oncology Group | 1780 | 2017-05-25 | 2026-08-25 |
| Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma Biopsy Procedure, Bone Marrow Aspiration, Bone Marrow Biopsy - Ganglioneuroblastoma, Localized Resectable Neuroblastoma | Phase 3 | Active not recruiting | Children's Oncology Group | 391 | 2014-08-08 | 2026-10-13 |
| Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer Atezolizumab, Biopsy Procedure, Biospecimen Collection - Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 | Phase 2 / Phase 3 | Suspended | National Cancer Institute (NCI) | 613 | 2013-03-22 | 2026-11-02 |
Squamous Cell Carcinoma of Head and Neck (2) · Adenocarcinoma of Lung (1) · Anal Canal Carcinoma (1) · Anus Neoplasms (1) · Appendiceal Neoplasms (1) · Carcinoma, Embryonal (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Squamous Cell (1) · Colorectal Neoplasms (1) · Endodermal Sinus Tumor (1) · Fallopian Tube Neoplasms (1) · Ganglioneuroblastoma (1) · Lung Neoplasms (1) · Lymphoma (1) · Neoplasms, Germ Cell and Embryonal (1)
Children's Oncology Group (5) · National Cancer Institute (NCI) (5) · NRG Oncology (2) · City of Hope Medical Center (1) · SWOG Cancer Research Network (1)
United States (13) · Canada (8) · Australia (3) · New Zealand (3) · Puerto Rico (3) · Saudi Arabia (2) · Hong Kong (1) · India (1) · Ireland (1) · Japan (1) · Peru (1) · South Korea (1) · United Kingdom (1)
A. L Frazier (1) · Amanda N Fader (1) · Bhuvana A Setty (1) · Christine M Bestvina (1) · Holly J Meany (1) · Jean H Hoffman-Censits (1) · Josephine H Haduong (1) · Keith J August (1) · Lakshmi Rajdev (1) · Mariya Rozenblit (1) · Mustafa Raoof (1) · Nina N Sanford (1) · Paul M Harari (1) · Sue S Yom (1)
PMID 35613998, PMID 37783480, PMID 40058134
U10CA180886 (5), U10CA180868 (4), U10CA180820 (2), P30CA033572 (1), U10CA021661 (1), U10CA098543 (1), U10CA180821 (1), U10CA180888 (1)